ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,58
-0,37%
Bitcoin
59 879,06
-1,19%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Kronos Bio Inc (KRON)

  7. Kronos Bio Inc (KRON) Actualités

KRON Kronos Bio Inc

1,03
0,03 (3,00%)
30 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Kronos Bio Inc KRON NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,03 3,00% 1,03 22:55:41
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,01 1,00 1,06 1,03 1,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202422:01GLOBEKronos Bio to Present Clinical Update on Phase 1/2 Trial of..
21/3/202412:05GLOBEKronos Bio Reports Recent Business Progress and..
07/3/202422:05EDGAR2Form 8-K - Current report
07/3/202422:05GLOBEKronos Bio Announces Restructuring to Focus Resources on..
05/3/202422:44GLOBEKronos Bio To Present Three Posters at AACR 2024 Annual..
05/3/202413:00EDGAR2Form 8-K - Current report
27/2/202422:05GLOBEKronos Bio Announces Participation in 44th Annual Cowen..
24/2/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202402:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/2/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202402:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/1/202414:05EDGAR2Form 8-K - Current report
06/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:06GLOBEKronos Bio Announces Pipeline Update and p300 KAT Inhibitor..
13/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:00GLOBEKronos Bio Announces Participation in H.C. Wainwright 4th..
27/11/202322:05GLOBEKronos Bio Announces Participation in 35th Annual Piper..
13/11/202322:08EDGAR2Form 8-K - Current report
13/11/202322:05GLOBEKronos Bio Reports Recent Business Progress and..
13/11/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:11EDGAR2Form 8-K - Current report
02/11/202321:05GLOBEKronos Bio Announces Plan to Optimize Resource Allocation,..
02/11/202317:00GLOBEKronos Bio Presents Positive Preliminary Data from the Phase..
27/10/202314:00GLOBEKronos Bio To Present Positive Preliminary Data from Phase 1..
13/10/202318:30GLOBEKronos Bio Presents Positive Preliminary Data from Phase 1..
05/10/202314:00EDGAR2Form 8-K - Current report
04/10/202322:05GLOBEKronos Bio To Present Interim Data from Phase 1 Dose..
18/9/202314:00EDGAR2Form 8-K - Current report
17/8/202314:00EDGAR2Form 8-K - Current report
17/8/202314:00GLOBEKronos Bio Announces Departure of Chief Financial Officer..
08/8/202322:05GLOBEKronos Bio Reports Recent Business Progress and..
08/8/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:03EDGAR2Form 8-K - Current report
07/7/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202314:00GLOBEKronos Bio Names Marc Besman, Ph.D., as Senior Vice..
01/6/202322:05GLOBEKronos Bio Announces Participation in Upcoming Investor..
10/5/202322:05GLOBEKronos Bio Reports Recent Business Progress and..

Dernières Valeurs Consultées

NASDAQ
KRON
Kronos Bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés